Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
The oversubscribed financing was led by Suvretta Capital Management, LLC (“Suvretta Capital”) with participation from new and existing investors including Adage Capital Partners L.P., Nantahala Capital, multiple healthcare-focused funds, and a leading mutual fund.
- The oversubscribed financing was led by Suvretta Capital Management, LLC (“Suvretta Capital”) with participation from new and existing investors including Adage Capital Partners L.P., Nantahala Capital, multiple healthcare-focused funds, and a leading mutual fund.
- Gross proceeds from the PIPE financing total approximately $40.0 million, before deducting offering expenses.
- The closing of the PIPE financing is subject to customary closing conditions and is expected to occur by April 22, 2024.
- Leerink Partners and Citizens JMP are acting as placement agents for the PIPE financing.